| 000 | 01695 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517052900.0 | ||
| 264 | 0 | _c20160916 | |
| 008 | 201609s 0 0 eng d | ||
| 022 | _a1879-0267 | ||
| 024 | 7 |
_a10.1016/j.injury.2015.07.013 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAlt, Volker | |
| 245 | 0 | 0 |
_aEffects of recombinant human Bone Morphogenetic Protein-2 (rhBMP-2) in grade III open tibia fractures treated with unreamed nails-A clinical and health-economic analysis. _h[electronic resource] |
| 260 |
_bInjury _cNov 2015 |
||
| 300 |
_a2267-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aBone Morphogenetic Protein 2 |
| 650 | 0 | 4 |
_aBone Morphogenetic Proteins _xeconomics |
| 650 | 0 | 4 |
_aBone Transplantation _xeconomics |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFracture Fixation, Intramedullary _xeconomics |
| 650 | 0 | 4 | _aFracture Healing |
| 650 | 0 | 4 |
_aFractures, Open _xeconomics |
| 650 | 0 | 4 |
_aGermany _xepidemiology |
| 650 | 0 | 4 |
_aHealth Care Costs _xstatistics & numerical data |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aModels, Economic |
| 650 | 0 | 4 |
_aReoperation _xeconomics |
| 650 | 0 | 4 |
_aTibial Fractures _xeconomics |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUnited Kingdom _xepidemiology |
| 700 | 1 | _aBorgman, Benny | |
| 700 | 1 | _aEicher, Alexander | |
| 700 | 1 | _aHeiss, Christian | |
| 700 | 1 | _aKanakaris, Nikolaos K | |
| 700 | 1 | _aGiannoudis, Peter V | |
| 700 | 1 | _aSong, Fujian | |
| 773 | 0 |
_tInjury _gvol. 46 _gno. 11 _gp. 2267-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.injury.2015.07.013 _zAvailable from publisher's website |
| 999 |
_c25266025 _d25266025 |
||